# Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

> **NCT00770874** · PHASE3 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 375 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** S-1 + Cisplatin (arm A)
- **DRUG:** Cisplatin (arm B)

## Key facts

- **NCT ID:** NCT00770874
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770874, "Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00770874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*